Solitary Rectal Ulcer Syndrome and Pelvic Pain

  • Martin Farmer


Solitary rectal ulcer syndrome (SRUS) is a benign functional bowel disorder. It was first described by Madigan and Morson from St. Mark’s Hospital in 1969 [1]. The term is misleading as none or multiple ulcers may be present. Etiological theories have included hormonal, behavioral, structural, and mechanical causes. Unfortunately, there is very little definitive evidence regarding not only the etiology but also the treatment of this condition.


Botulinum Toxin Rectal Prolapse Interstitial Cystitis Chronic Pelvic Pain Argon Plasma Coagulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Madigan MR, Morson BC. Solitary ulcer of the rectum. Gut. 1969;10:871–81.PubMedCrossRefGoogle Scholar
  2. 2.
    Womack NR, Williams NS, Holmfield JHM, Morrison JFB. Pressure and prolapse-the cause of solitary rectal ulceration. Gut. 1987;28:1228–33.PubMedCrossRefGoogle Scholar
  3. 3.
    Morio O, Meurette G, Desfourneaux V, D’Halluin PN, Bretagne JF, Siproudhis L. Anorectal physiology in solitary rectal ulcer syndrome: a case-matched series. Dis Colon Rectum. 2005;48:1917–22.PubMedCrossRefGoogle Scholar
  4. 4.
    Marshall M, Halligan S, Fotheringham T, Bartram C, Nicholls RJ. Predictive value of internal anal sphincter thickness for diagnosis of rectal intussusception in patients with solitary rectal ulcer syndrome. Br J Surg. 2002;89:1281–5.PubMedCrossRefGoogle Scholar
  5. 5.
    Vaizey CJ, Roy AJ, Kamm MA. Prospective evaluation of the treatment of solitary rectal ulcer syndrome with biofeedback. Gut. 1997;41:817–20.PubMedCrossRefGoogle Scholar
  6. 6.
    Meurette G, Siprouhdis L, Regenet N, Frampas E, Proux M, Lehur PA. Poor symptomatic relief and quality of life in patients treated for “solitary rectal ulcer syndrome without external rectal prolapse”. Int J Colorectal Dis. 2008;23:521–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Chong VH, Jalihal A. Solitary rectal ulcer syndrome: characteristics, outcomes and predictive profiles for persistent bleeding per rectum. Singapore Med J. 2006;47:1063–8.PubMedGoogle Scholar
  8. 8.
    da Fonseca LM, Souza Fde L, Arantes V, da Silva RG. Giant refractory solitary rectal ulcer syndrome treated with topical sucralfate. Int J Colorectal Dis. 2010;25:1025–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Morgan V, Pickens D, Gautam S, Kessler R, Metz H. Amitriptyline reduces rectal pain related activation of the anterior cingulated cortex in patients with irritable bowel syndrome. Gut. 2005;54:601–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Somani SK, Ghosh A, Avasthi G, et al. Healing of solitary rectal ulcers with multiple sessions of argon plasma coagulation. Dig Endosc. 2010;22:107–11.PubMedCrossRefGoogle Scholar
  11. 11.
    Boccasanta P, Venturi M, Calabro G, Maciocco M, Roviaro GC. Stapled transanal rectal resection in solitary rectal ulcer associated with prolapse of the rectum: a prospective study. Dis Colon Rectum. 2008;51:348–54.PubMedCrossRefGoogle Scholar
  12. 12.
    Goede A, Glancy D, Carter H, Mills A, Mabey K, Dixon A. Medium term results of stapled transanal rectal resection (STARR) for obstructed defecation and symptomatic rectal-anal intussusception. Colorectal Dis. 2011;13(9):1052–7. 2010 Aug 31 [Epub ahead of print].PubMedCrossRefGoogle Scholar
  13. 13.
    Lenisa L, Schwander O, Stuto A, et al. STARR with Contour® TranstarTM: prospective multicentre European study. Colorectal Dis. 2009;11:821–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Felt-Bersma RJ, Cuesta MA. Rectal prolapse, rectal intussusception, rectocele and solitary rectal ulcer syndrome. Gastroenterol Clin North Am. 2001;30:199–222.PubMedCrossRefGoogle Scholar
  15. 15.
    Samaranayake CB, Luo C, Plank AW, Merrie AEH, Plank LD, Bisset IP. Systematic review on ventral rectopexy for rectal prolapse and intussusception. Colorectal Dis. 2010;12:504–12.PubMedCrossRefGoogle Scholar
  16. 16.
    D’Hoare A, Cadoni R, Penninckx F. Long-term outcome of laparoscopic ventral rectopexy for total rectal prolapse. Br J Surg. 2004;91:1500–5.CrossRefGoogle Scholar
  17. 17.
    Slawik S, Soulsby R, Carter H, Payne H, Dixon AR. Laparoscopic ventral rectopexy, posterior colporrhaphy and vaginal sacrocolpopexy for the treatment of recto-genital prolapse and mechanical outlet obstruction. Colorectal Dis. 2008;10:138–43.PubMedGoogle Scholar
  18. 18.
    Van den Esschert JW, van Geloven AA, et al. Laparoscopic ventral rectopexy for obstructed defecation syndrome. Surg Endosc. 2008;22:2728–32.PubMedCrossRefGoogle Scholar
  19. 19.
    Boons P, Collinson R, Cunningham C, Lindsey I. Laparoscopic ventral rectopexy for external rectal prolapse improves and avoids de novo constipation. Colorectal Dis. 2010;10:526–32.Google Scholar
  20. 20.
    Laufer MR, Goetein L, Bush M, Cramer DW, Emans SJ. Prevalence of endometriosis in adolescent girls with chronic pelvic pain not responding to conventional therapy. J Pediatr Adolesc Gynecol. 1997;10:199–202.PubMedGoogle Scholar
  21. 21.
    The American Fertility Society. Revised American Fertility Society classification of endometriosis. Fertil Steril. 1985;43:351–2.Google Scholar
  22. 22.
    Attaran M, Falcone T, Goldberg J. Endometriosis: still tough to diagnose and treat. Cleve Clin J Med. 2002;69:647–53.PubMedCrossRefGoogle Scholar
  23. 23.
    Daniels J, Gray R, Hills RK, LUNA Trial Collaboration, et al. Laparoscopic uterosacral nerve ablation trial for alleviating chronic pelvic pain: a randomized controlled trial. JAMA. 2009;2:55–961.Google Scholar
  24. 24.
    Tu FF, Hahn D, Steege JF. Pelvic congestion syndrome-associated pelvic pain; a systematic review of diagnosis and management. Obstet Gynecol Surv. 2010;65:332–40.PubMedCrossRefGoogle Scholar
  25. 25.
    Rozenblit AM, Ricci ZJ, Tuvia J, Amis Jr ES. Incompetent and dilated ovarian veins: a common CT finding in asymptomatic parous women. AJR Am J Roentgenol. 2001;176:119–22.PubMedGoogle Scholar
  26. 26.
    Asciutto G, Mumme A, Marpe B, Koster O, Ascuitto KC, Geier B. MR venography in the detection of pelvic venous congestion. Eur J Vasc Endovasc Surg. 2008;36:491–6.PubMedCrossRefGoogle Scholar
  27. 27.
    Freedman J, Ganeshan A, Crowe PM. Pelvic congestion syndrome: the role of interventional radiology in the treatment of chronic pelvic pain. Postgrad Med J. 2010;86:704–10.PubMedCrossRefGoogle Scholar
  28. 28.
    Payne RA, O’Conner RC, Kressin M, Guralnick ML. Endoscopic ablation of Hunner’s lesions in interstitial cystitis patients. Can Urol Assoc J. 2009;3:473–7.PubMedGoogle Scholar
  29. 29.
    Smith CP, Radziszewski A, Somogyi GT, Boone TB, Chancellor MB. Botulinum toxin A has antinociceptive effects in treating interstitial cystitis. Urology. 2004;64:871–5.PubMedCrossRefGoogle Scholar
  30. 30.
    Zabihi N, Mourtzinos A, Maher MG, Raz S, Rodriguez LV. Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome and chronic pelvic pain. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:553–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Comiter CV. Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J Urol. 2003;169:1369–73.PubMedCrossRefGoogle Scholar
  32. 32.
    Chiarioni G, Nardo A, Vantini I, Romito A, Whitehead WE. Biofeedback is superior to electrogalvanic stimulation and massage for treatment of levator ani syndrome. Gastroenterology. 2010;138:1321–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Nicosia JF, Abcarian H. Levator syndrome. A treatment that works. Dis Colon Rectum. 1985;28:406–8.PubMedCrossRefGoogle Scholar
  34. 34.
    Park DH, Yoon SG, Kim KU, et al. Comparison study between electrogalvanic stimulation and local injection therapy in levator ani syndrome. Int J Colorectal Dis. 2005;20:272–6.PubMedCrossRefGoogle Scholar
  35. 35.
    Rao SSC, Poulson J, Mata M, Zimmerman B. Clinical trial: effects of botulinum toxin A on levator ani syndrome: a double blind. Placebo controlled study. Aliment Pharmacol Ther. 2009;29:985–91.PubMedCrossRefGoogle Scholar
  36. 36.
    De Parades V, Etienney I, Bauer P, Taouk M, Atienza P. Proctalgia fugax: demographic and clinical characteristics. What every doctor should know from a prospective study of 54 patients. Dis Colon Rectum. 2007;50:893–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Katsinelos P, Kalomenopoulou M, Christodoulou K, et al. Treatment of proctalgia fugax with botulinum A toxin. Eur J Gastroenterol Hepatol. 2001;13:1371–3.PubMedCrossRefGoogle Scholar
  38. 38.
    Bouquet J, Moore N, Lhuintre JP, Boismare F. Diltiazem for proctalgia fugax. Lancet. 1986;28:1493.CrossRefGoogle Scholar
  39. 39.
    Wright JE. Trial of inhaled salbutamol for proctalgia fugax. Lancet. 1991;9:359.CrossRefGoogle Scholar
  40. 40.
    Hompes R, Lindsey I. Chronic anorectal pain: a pathophysiological approach. In: Lindsay I, Nugent K, Dixon T, editors. Pelvic floor disorders for the colorectal surgeon. Oxford: Oxford University Press; 2011.Google Scholar
  41. 41.
    Benson J, Griffis K. Pudendal neuralgia, a severe pain syndrome. Am J Obstet Gynecol. 2005;192:1663–8.PubMedCrossRefGoogle Scholar
  42. 42.
    NICE Guidance. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin. 2008.
  43. 43.
    Robert R, Labatt JJ, Bensignor M, et al. Decompression and transposition of the pudendal nerve in pudendal neuralgia: a randomized controlled trial and long term evaluation. Eur Urol. 2005;47:403–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2012

Authors and Affiliations

  1. 1.Department of General SurgeryUniversity Hospital North StaffordshireStoke-on-Trent, North StaffsUK

Personalised recommendations